Docetaxel, Capecitabine, and Cisplatin in Treating Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as docetaxel, capecitabine, and cisplatin, work
in different ways to stop tumor cells from dividing so they stop growing or die. Giving more
than one chemotherapy drug may kill more tumor cells.
PURPOSE: This phase I trial is studying the side effects and best dose of docetaxel,
capecitabine, and cisplatin in treating patients with metastatic or unresectable solid
tumors.